Xtl Biopharmaceuticals (XTLB) Other Operating Expenses (2009 - 2013)
Xtl Biopharmaceuticals (XTLB) posted Other Operating Expenses of $3000.0 for Q4 2013, down 99.71% sequentially from $1.0 million in Q3 2013, and down 57.14% YoY from $7000.0 in Q4 2012.
Xtl Biopharmaceuticals (XTLB) Other Operating Expenses (2009 - 2013) Analysis & Trends
Xtl Biopharmaceuticals has reported Other Operating Expenses for 4 years, with the latest figure at $3000.0 in Q4 2013.
- Quarterly Other Operating Expenses fell 57.14% year-over-year to $3000.0 in Q4 2013, while the trailing twelve-month figure through Sep 2014 was $3000.0 (down 99.72% YoY) and the FY2015 annual result came in at -$10000.0, down 107.04% from the prior year.
- Other Operating Expenses eased to $3000.0 in Q4 2013 per XTLB's latest filing, from $1.0 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $1.0 million in Q3 2013 and troughed at -$783000.0 in Q4 2011.
- A 4-year average of $129090.9 and a median of $7000.0 in 2012 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2012 and 2013: Other Operating Expenses soared 100.89% in 2012, then slumped 99.12% in 2013.
- Over 4 years, Other Operating Expenses stood at -$5000.0 in 2009, then tumbled by 15560.0% to -$783000.0 in 2011, then soared by 100.89% to $7000.0 in 2012, then sank by 57.14% to $3000.0 in 2013.
- According to Business Quant data, Other Operating Expenses over the past three periods registered $3000.0, $1.0 million, and $3000.0 for Q4 2013, Q3 2013, and Q2 2013 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Xtl Biopharmaceuticals | 2.64 Bn | 2.64 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2013 | 3,000.00 |
| Sep 30, 2013 | 1.05 Mn |
| Jun 30, 2013 | 3,000.00 |
| Mar 31, 2013 | 7,000.00 |
| Dec 31, 2012 | 7,000.00 |
| Sep 30, 2012 | 795,000.00 |
| Mar 31, 2012 | 795,000.00 |
| Dec 31, 2011 | -783,000.00 |
| Jun 30, 2011 | -592,000.00 |
| Dec 31, 2009 | -5,000.00 |
| Sep 30, 2009 | 144,000.00 |